Accéder au contenu
Merck

Preso1 dynamically regulates group I metabotropic glutamate receptors.

Nature neuroscience (2012-05-09)
Jia-Hua Hu, Linlin Yang, Paul J Kammermeier, Chester G Moore, Paul R Brakeman, Jiancheng Tu, Shouyang Yu, Ronald S Petralia, Zhe Li, Ping-Wu Zhang, Joo Min Park, Xinzhong Dong, Bo Xiao, Paul F Worley
RÉSUMÉ

Group I metabotropic glutamate receptors (mGluRs), including mGluR1 and mGluR5, are G protein–coupled receptors (GPCRs) that are expressed at excitatory synapses in brain and spinal cord. GPCRs are often negatively regulated by specific G protein–coupled receptor kinases and subsequent binding of arrestin-like molecules. Here we demonstrate an alternative mechanism in which group I mGluRs are negatively regulated by proline-directed kinases that phosphorylate the binding site for the adaptor protein Homer, and thereby enhance mGluR–Homer binding to reduce signaling. This mechanism is dependent on a multidomain scaffolding protein, Preso1, that binds mGluR, Homer and proline-directed kinases and that is required for their phosphorylation of mGluR at the Homer binding site. Genetic ablation of Preso1 prevents dynamic phosphorylation of mGluR5, and Preso1(−/−) mice exhibit sustained, mGluR5-dependent inflammatory pain that is linked to enhanced mGluR signaling. Preso1 creates a microdomain for proline-directed kinases with broad substrate specificity to phosphorylate mGluR and to mediate negative regulation.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Anticorps monoclonal anti-β-actine antibody produced in mouse, clone AC-74, ascites fluid
Sigma-Aldrich
Anticorps anti-NR1, CT, Upstate®, from mouse